This study also carried out on behalf of GARFIELD-AF investigators*. We thank the physicians, nurses, and patients involved in GARFIELD-AF. Editorial support was provided by Saverio Virdone (TRI, London, UK).
This work was supported by an unrestricted research grant from Bayer AG (Berlin, Germany) to the Thrombosis Research Institute (London, UK). The funding source had no involvement in the data collection, data analysis, or data interpretation.
No funding or sponsorship was received for this study or publication of this article. The Rapid Service Fee was funded by the authors.
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Begum Yetis Sayin , Wael Al Mahmeed , Hany Ibrahim Ragy, Atef Elbahry, Saverio Virdone, Ajay K. Kakkar, Murat Ersanlı and Ali Oto contributed to the study design. Begum Yetis Sayin , Wael Al Mahmeed , Hany Ibrahim Ragy, Atef Elbahry, Saverio Virdone, Ajay K. Kakkar, Murat Ersanlı and Ali Oto contributed to data acquisition. Saverio Virdone analysed the data. All authors contributed to data interpretation. All authors critically reviewed the report and approved the final manuscript.
Begum Yetis Sayin , Wael Al Mahmeed , Hany Ibrahim Ragy, Atef Elbahry, Murat Ersanlı and Ali Oto have nothing to disclose. Saverio Virdone has no direct competing interests but has received sponsorship or consulted for companies with an interest in anticoagulation including Bayer, BI and Pfizer.
Compliance with Ethics Guidelines
All patients provided written informed consent to participate. Independent ethics committee and hospital-based institutional review board approvals were obtained, as necessary, for the registry protocol (protocol number: TRI08888, project code: IPAA4663). The registry is conducted in accordance with the Declaration of Helsinki and guidelines from the International Conference on Harmonisation on Good Clinical Practice and Good Pharmaco-epidemiological Practice, and adheres to all applicable national laws and regulations.
All relevant data are within the paper/as supplementary information files. The datasets generated during the current study are not expected to be made publicly available as participant consent forms and ethics approval did not include permission for secondary use, with access to data only approved for researchers involved in the analysis.